Ignite Creation Date:
2024-05-05 @ 6:52 PM
Last Modification Date:
2024-10-26 @ 9:37 AM
Study NCT ID:
NCT00557908
Status:
COMPLETED
Last Update Posted:
2017-10-06
First Post:
2007-11-13
Brief Title:
The Von Willebrand Disease VWD International Prophylaxis Study
Sponsor:
Skane University Hospital
Organization:
Skane University Hospital
Study Overview
Official Title:
The VWD International Prophylaxis VIP Study
Status:
COMPLETED
Status Verified Date:
2017-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VIP
Brief Summary:
The von Willebrand Disease Prophylaxis Network VWD PN is an international study group formed with the goal of investigating the role of prophylaxis in clinically severe VWD that is non-responsive to other treatments
Detailed Description:
The most common indications for vWD prophylaxis included joint bleeding epistaxis gastrointestinal GI bleeding and menorrhagia Thus an effort to establish optimal treatment regimens for these indications through a period of prospective evaluation is the primary focus of this research Other goals include a retrospective study of the effect of prophylaxis on bleeding frequency and a retrospective natural history study of GI bleeding in VWD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None